- Home
- INLF vs RDHL Comparison
INLF vs RDHL Comparison
Compare INLF & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INLF | RDHL |
|---|---|---|
| Founded | 2016 | 2009 |
| Country | China | Israel |
| Employees | N/A | 23 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 4.0M |
| IPO Year | 2023 | 2012 |
Fundamental Metrics
Financial Performance| Metric | INLF | RDHL |
|---|---|---|
| Price | $3.85 | $0.66 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 24.1K |
| Earning Date | 03-06-2026 | 04-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $381.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.02 | $0.57 |
| 52 Week High | $9.91 | $2.79 |
Technical Indicators
Market Signals| Indicator | INLF | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 48.05 | 45.57 |
| Support Level | $3.80 | $0.57 |
| Resistance Level | $4.72 | $1.07 |
| Average True Range (ATR) | 0.37 | 0.03 |
| MACD | -0.17 | 0.01 |
| Stochastic Oscillator | 2.14 | 62.75 |
Price Performance
Historical ComparisonAbout INLF INLIF LIMITED
INLIF Ltd, through its subsidiary, is engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms. In addition, it offers installation and warranty services for manipulator arms, and accessories and raw materials for manipulator arms. Its portfolio includes injection molding machine-dedicated manipulator arms, including transverse single and double-axis manipulator arms, transverse and longitudinal multi-axis manipulator arms, and large bullhead multi-axis manipulator arms.
About RDHL Redhill Biopharma Ltd.
RedHill Biopharma Ltd is a specialty biopharmaceutical company mainly focused on the U.S. development and commercialization of drugs for GI diseases, infectious diseases, and oncology. The Company is mainly focused on the advancement of its development pipeline of clinical-stage therapeutic candidates and also commercializes its GI-related product, Talicia (omeprazole, amoxicillin, and rifabutin) in the U.S. Its therapeutic candidates include opaganib, RHB-204, RHB-104, RHB-102 (Bekinda), and RHB-107.